Showing results (971-980 of 1,447) with videos related to
Sort By:
Pageof 145
Proteomics. Clinical Applications|February 13, 2013
Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapyTimothy Chao, Jon J Ladd, Ji Qiu, et al.Proteomics. Clinical Applications|February 19, 2013
Proteomic analysis of the aqueous humor in patients with wet age-related macular degenerationJiaqi Yao, Xiaoyi Liu, Qin Yang, et al.Proteomics. Clinical Applications|May 4, 2013
Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profilingAtsushi Kuno, Takashi Sato, Hiroko Shimazaki, et al.Proteomics. Clinical Applications|May 4, 2013
O-GlcNAcomics--Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnosticsRonald J Copeland, Guanghui Han, Gerald W HartProteomics. Clinical Applications|May 4, 2013
Enrichment strategies in glycomics-based lung cancer biomarker developmentL Renee Ruhaak, Uyen Thao Nguyen, Carol Stroble, et al.Proteomics. Clinical Applications|August 6, 2014
Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cellsLorenzo Colarossi, Lorenzo Memeo, Cristina Colarossi, et al.Proteomics. Clinical Applications|January 4, 2012
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles)Christopher R Kinsinger, James Apffel, Mark Baker, et al.Proteomics. Clinical Applications|December 12, 2012
Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategiesCécile Thirant, Julie Gavard, Marie-Pierre Junier, et al.Proteomics. Clinical Applications|August 29, 2013
Isotope dilution assay in peptide quantification: the challenge of microheterogeneity of internal standardAlexander V Stoyanov, Eduard Rogatsky, Daniel Stein, et al.Proteomics. Clinical Applications|May 15, 2013
Development of a label-free LC-MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapyBrian Morrissey, Carmel O'Shea, John Armstrong, et al.Pageof 145